Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

Lancet Global Health
Dec 2018 Volume 6 Number 12 e1253-e1404
http://www.thelancet.com/journals/langlo/issue/current

Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
The Coalition for Epidemic Preparedness Innovations was established in 2016, to develop vaccines that can contribute to preparedness for outbreaks of epidemic infectious diseases. Evidence on vaccine development costs for such diseases is scarce. Our goal was to estimate the minimum cost for achieving vaccine research and development preparedness targets in a portfolio of 11 epidemic infectious diseases, accounting for vaccine pipeline constraints and uncertainty in research and development preparedness outcomes.
Dimitrios Gouglas, Tung Thanh Le, Klara Henderson, Aristidis Kaloudis, Trygve Danielsen, Nicholas Caspersen Hammersland, James M Robinson, Penny M Heaton, John-Arne Røttingen